We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

VOW3:XETRVolkswagen AG Pref Analysis

Data as of 2026-03-10 - not real-time

€90.30

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Volkswagen AG trades at €90.3, sitting well below its 20‑day (≈€98.7) and 50‑day (≈€101.1) simple moving averages and also under the 200‑day SMA (≈€96.9), signaling a short‑term bearish bias. The RSI of 33.5 points to oversold conditions, while the MACD remains in a bearish configuration (line below signal), though trading volume is on the rise and the price is hovering just above the identified support level of €87.6. Volatility is elevated at over 30% on a 30‑day basis, yet the computed beta of ~0.27 suggests limited market‑wide systematic risk, and the Fear & Greed Index sits in “Extreme Greed” territory, reflecting strong investor appetite.
Fundamentally, the stock appears deeply discounted with a trailing P/E of 6.7, forward P/E of 3.5, P/B of 0.27 and a price‑to‑sales of 0.14, while offering a generous dividend yield of 7.24%. However, free cash flow is markedly negative (‑€83.6 bn) and leverage is high (debt‑to‑equity >130), raising concerns about dividend sustainability. Analysts (21) rate the stock as a “buy” with a median price target of €115, implying roughly 30% upside, which aligns with the calculated upside/downside potential.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 5/10

Key Factors

  • Price below short‑term moving averages
  • Bearish MACD histogram
  • Oversold RSI suggesting limited downside

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Substantial valuation discount (low P/E, P/B)
  • High dividend yield relative to peers
  • Analyst consensus target indicating ~30% upside

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • Diversified brand portfolio and EV transition roadmap
  • Potential earnings recovery as operating margins improve
  • Attractive yield if cash flow stabilises

Key Metrics & Analysis

Financial Health

Revenue Growth2.30%
Profit Margin2.26%
P/E Ratio6.7
ROE3.58%
ROA1.85%
Debt/Equity130.13
P/B Ratio0.3
Op. Cash Flow€15.4B
Free Cash Flow€-83611090944

Technical Analysis

TrendNeutral
RSI33.5
Support€87.60
Resistance€105.00
MA 20€98.71
MA 50€101.09
MA 200€96.87
MACDBearish
VolumeIncreasing
Fear & Greed Index76.5

Valuation

Target Price€117.46
Upside/Downside30.07%
GradeUndervalued
TypeBlend
Dividend Yield7.24%

Risk Assessment

Beta0.27
Volatility32.24%
Sector RiskMedium
Reg. RiskHigh
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.